In summary, our current study indicates the new-onset and persisting insulin resistance in COVID-19 patients, and elucidates the potential underlying mechanisms that involved metabolic factors including MPO, apelin, and myostatin, which are transcriptionally regulated by REST upon SARS-CoV-2 infection. Here, APLN is linked to COVID-19.